Navigation Links
Thoratec Announces Presentations At Investor Conferences For December 2013
Date:11/27/2013

PLEASANTON, Calif., Nov. 27, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences.

On Wednesday, December 4, the company will participate in the Piper Jaffray 25th Annual Health Care Conference. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 12:00 p.m., Eastern Standard Time (9:00 a.m., Pacific Standard Time). A webcast of the presentation will be available at http://www.media-server.com/m/p/2k89k7xb, or on the company's website at http://www.thoratec.com.

On Tuesday, December 10, Thoratec will participate in the Oppenheimer 24th Annual Healthcare Conference. The presentation by Taylor C. Harris, Vice President and Chief Financial Officer, will begin at 2:10 p.m., Eastern Standard Time (11:10 a.m., Pacific Standard Time).  A webcast of the presentation will be available at http://www.veracast.com/webcasts/opco/healthcare2013/08112471883.cfm, or on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Announces Presentations At Investor Conferences For November 2013
2. Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be Webcast
3. Thoratec Presentation At Bank of America Merrill Lynch 2013 Health Care Conference To Be Webcast
4. Thoratec Schedules First Quarter Conference Call, Webcast
5. Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast
6. Thoratec Presentation at Leerink Swann Global Healthcare Conference to Be Webcast
7. Thoratec Schedules Fourth Quarter Conference Call, Webcast
8. Thoratec Presentation At Oppenheimer 23rd Annual Healthcare Conference To Be Webcast
9. Thoratec Presentation At Piper Jaffray 24th Annual Healthcare Conference To Be Webcast
10. Thoratec Presentation At Credit Suisse 2012 Healthcare Conference To Be Webcast
11. Thoratec Reports Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):